This Week on Drug Topics: March 8 to 12
Here’s a preview of the featured content to watch for this week on Drug Topics®.
Coronavirus Research News
With an estimated 90.4 million COVID-19 vaccine doses administered and 523,000 deaths in the US as of this article’s press time, keeping up with pandemic news is more important than ever. Check back to Drug Topics®to stay informed on the latest coronavirus-related news and research.
Read more coronavirus-related news.
Medical World News Updates
In an interview with Drug Topics®, Patrick Bordnick, dean of the Tulane University School of Social Work, guides us through some key self-care recommendations, featuring the school’s diverse set of self-care resources.
Drug Topics® Journal, March 2021 Digital Edition
The March 2021 digital edition of Drug Topics Journal will soon be available on DrugTopics.com. In this issue, pharmacists offer advice on how to approach complementary and integrative therapies, and our cover story, in celebration of Women’s History Month, highlights the achievements from women in pharmacy practice.
Read more Drug Topics Journal issues.
Topics in Migraine Research
Christine Blank writes on a recent meta-analysis exploring the comorbid relationship between asthma and migraine. Additionally, an upcoming article on Drug Topics® this week will dive into research on the effect of exercise on migraine symptoms.
Visit our migraine clinical resource center for more information.
APhA 2021 Annual Meeting & Exposition
The American Pharmacists Association (APhA) 2021 Annual Meeting & Exposition kicks off virtually on March 12.
Check back to our conference coverage page for more later this week.
In Case You Missed It: NCPA Survey Finds Most Adults Prefer Local Pharmacist Over Mail Order
Results of a new national survey showed that more than 8 in 10 adults prefer their local pharmacists over mail order services.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
